Measurement of urinary neutrophil gelatinase-associated lipocalin (uNGAL) has been demonstrated to be an early, non-invasive marker of AKI due to a variety of etiologies, such as cardiac surgery[3], intravenous contrast administration[4], critical care settings[5], and kidney transplantation[6]. Here, LCN2 is linked to acute kidney injury.